Performance analysis of Sangamo Therapeutics (SGMO)
Annual Return
Over the past 3 years, SGMO has had an average annual return of -62.52%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, SGMO has had an average annual return of -62.83%, underperforming the benchmark SPY, which returned +12.78% annual.
Over the past 10 years, SGMO has had an average annual return of -35.42%, underperforming the benchmark SPY, which returned +14.91% annual.
Since Apr 6, 2000, SGMO has had an average annual return of -18.31%, underperforming the benchmark SPY, which returned +8.15% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.44% | -58.79% | +87.53% | -82.69% | -58.13% | -51.94% | +86.43% | -27.09% | -30.00% | +437.78% | -66.60% | -39.98% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +9.51% | +131.09% | +111.61% | -57.22% | +12.16% | +70.10% | -73.27% | +97.31% | +63.75% | -32.83% | +9.69% | +81.69% |
| 2002 | 2001 | 2000 | |||||||||
| -67.77% | -52.10% | +29.48% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +27.60% | -19.38% | -42.86% | -51.83% | +83.54% | -66.21% | +0% | -82.44% | |||||
| 2025 | +20.68% | -17.14% | -35.75% | +17.93% | -39.77% | +16.18% | -0.56% | -3.36% | +29.57% | -11.19% | -22.92% | -8.82% | -58.79% |
| 2024 | -16.07% | +154.13% | -42.21% | -23.15% | +9.65% | -36.53% | +118.49% | +8.27% | +2.13% | +96.35% | +32.95% | -54.90% | +87.53% |
| 2023 | +11.13% | -12.60% | -42.27% | -16.51% | -23.77% | +15.99% | +1.16% | -26.23% | -38.20% | +5.03% | -31.58% | +26.22% | -82.69% |
| 2022 | -19.60% | -3.00% | -0.67% | -28.56% | -12.05% | +13.41% | +3.64% | +25.87% | -9.26% | -10.42% | -16.64% | -14.20% | -58.13% |
| 2021 | -12.47% | -15.89% | +9.06% | -5.99% | -8.49% | +11.04% | -19.97% | +3.44% | -9.07% | -9.88% | +2.10% | -9.54% | -51.94% |
| 2020 | -12.43% | +16.38% | -25.32% | +27.94% | +37.29% | -19.92% | +20.86% | +1.89% | -14.36% | +9.42% | -3.39% | +56.22% | +86.43% |
| 2019 | +1.82% | -22.92% | +5.88% | +22.53% | -25.15% | +23.08% | +11.52% | -9.24% | -16.98% | +0% | +19.34% | -22.49% | -27.09% |
| 2018 | +27.13% | +14.86% | -20.67% | -16.84% | +4.12% | -13.68% | -3.87% | +33.69% | -7.12% | -25.25% | -2.37% | -7.20% | -30.00% |
| 2017 | +14.77% | +29.99% | +14.30% | -7.70% | +41.67% | +29.41% | -2.28% | +55.25% | +12.35% | -17.33% | +30.64% | +1.24% | +437.78% |
Drawdown analysis of Sangamo Therapeutics (SGMO)
The maximum drawdown for the SGMO was -99.85%, occurring on Jun 23, 2026. This drawdown has not yet recovered.
The current SGMO drawdown is -99.85%.
Since Apr 6, 2000 SGMO has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.85% | Sep 1, 2000 | 6487 | Jun 23, 2026 | Ongoing | Ongoing | Ongoing |
| -56.01% | Apr 6, 2000 | 37 | May 31, 2000 | 8 | Jun 12, 2000 | 45 |
| -41.45% | Jul 24, 2000 | 6 | Aug 1, 2000 | 20 | Aug 29, 2000 | 26 |
| -20.02% | Jun 12, 2000 | 4 | Jun 16, 2000 | 2 | Jun 20, 2000 | 6 |
| -15.18% | Jul 11, 2000 | 2 | Jul 13, 2000 | 3 | Jul 18, 2000 | 5 |
| -6.25% | Jun 23, 2000 | 1 | Jun 26, 2000 | 1 | Jun 27, 2000 | 2 |
| -5.08% | Jul 5, 2000 | 1 | Jul 6, 2000 | 1 | Jul 7, 2000 | 2 |
| -2.71% | Jun 30, 2000 | 1 | Jul 3, 2000 | 1 | Jul 5, 2000 | 2 |
| -0.54% | Jun 28, 2000 | 1 | Jun 29, 2000 | 1 | Jun 30, 2000 | 2 |